AR052146A1 - Tetrahidropiridin-4-il-indoles con una combinacion de afinidad para receptores de dopamina-d2 y sitios de reabsorcion de serotonina, un metodo para su preparacion, composiciones farmaceuticas que los contienen y su empleo como medicamento para el tratamiento de enfermedades del snc - Google Patents
Tetrahidropiridin-4-il-indoles con una combinacion de afinidad para receptores de dopamina-d2 y sitios de reabsorcion de serotonina, un metodo para su preparacion, composiciones farmaceuticas que los contienen y su empleo como medicamento para el tratamiento de enfermedades del sncInfo
- Publication number
- AR052146A1 AR052146A1 ARP050105089A ARP050105089A AR052146A1 AR 052146 A1 AR052146 A1 AR 052146A1 AR P050105089 A ARP050105089 A AR P050105089A AR P050105089 A ARP050105089 A AR P050105089A AR 052146 A1 AR052146 A1 AR 052146A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- hydrogen
- indoles
- preparation
- dopamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Derivados de tetrahidropiridin-4-indoles con un doble modo de accion: inhibicion de la reabsorcion de la serotonina y afinidad para receptores de dopamina-D2, a métodos para la preparacion de estos compuestos y a compuestos intermedios utiles para la síntesis de dichos tetrahidropiridin-4-il-indoles. Uso de este compuesto para la fabricacion de un medicamento que tiene un efecto beneficioso. Derivados de tetrahidropiridin-4-il-indoles de formula (1), y tautomeros estereoisomeros, prodrogas, N- oxidos, sales farmacologicamente aceptables, hidratos y solvatos de los mismos, donde: R1 es hidrogeno, halogeno, alquilo C1-3 o alcoxi C1-3, CN o CF3; R2 es hidrogeno o alquilo C1-3; R3 es hidrogeno o alquilo C1-3; Z es hidrogeno o alquilo C1-3, alcoxi C1-3 o alquiltio C1-3; A es hidrogeno o alquilo C1-3; o A y Z conjuntamente forman un anillo de 5 o 6 miembros saturado o (parcialmente) insaturado que puede estar sustituido con halogeno, alquilo C1-3 o fenilo, donde el anillo Z representa carbono, azufre o nitrogeno. Reivindicacion 5: Un método para la preparacion de compuestos de acuerdo con la reivindicacion 1, caracterizado porque un compuesto que tiene la formula (2), se hace reaccionar bajo condiciones básicas con un compuesto que tiene la formula (3), teniendo los símbolos de las formulas los significados dados en la reivindicacion 1, y L es un así llamado grupo saliente.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04106351 | 2004-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR052146A1 true AR052146A1 (es) | 2007-03-07 |
Family
ID=34930005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050105089A AR052146A1 (es) | 2004-12-07 | 2005-12-06 | Tetrahidropiridin-4-il-indoles con una combinacion de afinidad para receptores de dopamina-d2 y sitios de reabsorcion de serotonina, un metodo para su preparacion, composiciones farmaceuticas que los contienen y su empleo como medicamento para el tratamiento de enfermedades del snc |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1828168A2 (es) |
JP (1) | JP2008523027A (es) |
KR (1) | KR20070091009A (es) |
CN (1) | CN101072770A (es) |
AR (1) | AR052146A1 (es) |
AU (1) | AU2005313387A1 (es) |
BR (1) | BRPI0518465A2 (es) |
CA (1) | CA2587936A1 (es) |
MX (1) | MX2007006757A (es) |
RU (1) | RU2007125692A (es) |
SA (1) | SA05260388B1 (es) |
TW (1) | TW200626575A (es) |
WO (1) | WO2006061373A2 (es) |
ZA (1) | ZA200704155B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2249649A4 (en) * | 2008-02-05 | 2012-09-26 | Watson Pharma Private Ltd | IMPROVED METHOD FOR THE MANUFACTURE OF PALIPERIDONE |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8900382D0 (en) * | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
WO2000069424A2 (en) * | 1999-05-12 | 2000-11-23 | Solvay Pharmaceuticals B.V. | Method of treating psychotic disorders |
AU2003257407A1 (en) * | 2002-08-29 | 2004-03-19 | H. Lundbeck A/S | S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof |
-
2005
- 2005-12-06 KR KR1020077015615A patent/KR20070091009A/ko not_active Application Discontinuation
- 2005-12-06 AU AU2005313387A patent/AU2005313387A1/en not_active Abandoned
- 2005-12-06 EP EP05817509A patent/EP1828168A2/en not_active Withdrawn
- 2005-12-06 AR ARP050105089A patent/AR052146A1/es not_active Application Discontinuation
- 2005-12-06 BR BRPI0518465-7A patent/BRPI0518465A2/pt not_active IP Right Cessation
- 2005-12-06 JP JP2007544893A patent/JP2008523027A/ja not_active Withdrawn
- 2005-12-06 CN CNA2005800419599A patent/CN101072770A/zh active Pending
- 2005-12-06 TW TW094142934A patent/TW200626575A/zh unknown
- 2005-12-06 SA SA5260388A patent/SA05260388B1/ar unknown
- 2005-12-06 RU RU2007125692/04A patent/RU2007125692A/ru not_active Application Discontinuation
- 2005-12-06 MX MX2007006757A patent/MX2007006757A/es active IP Right Grant
- 2005-12-06 CA CA002587936A patent/CA2587936A1/en not_active Abandoned
- 2005-12-06 WO PCT/EP2005/056501 patent/WO2006061373A2/en active Application Filing
-
2007
- 2007-05-22 ZA ZA200704155A patent/ZA200704155B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200704155B (en) | 2008-08-27 |
TW200626575A (en) | 2006-08-01 |
RU2007125692A (ru) | 2009-01-20 |
MX2007006757A (es) | 2007-11-09 |
CN101072770A (zh) | 2007-11-14 |
EP1828168A2 (en) | 2007-09-05 |
WO2006061373A2 (en) | 2006-06-15 |
CA2587936A1 (en) | 2006-06-15 |
JP2008523027A (ja) | 2008-07-03 |
AU2005313387A1 (en) | 2006-06-15 |
BRPI0518465A2 (pt) | 2008-11-18 |
SA05260388B1 (ar) | 2009-06-09 |
WO2006061373A3 (en) | 2006-09-21 |
KR20070091009A (ko) | 2007-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049291A1 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
AR052903A1 (es) | Compuestos de bis arilo y heteroarilo sustituidos como antagonistas selectivos de 5ht2a, composiciones farmaceuticas que los contienen y su empleo en el tratamiento de trastornos del sueno. | |
AR048642A1 (es) | Compuestos de metil-aril o heteroaril-amida sustituida utiles como antagonistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento | |
PE20091621A1 (es) | Derivados de amina como moduladores de la actividad de tlr y composiciones que los contienen | |
AR036659A1 (es) | Compuestos derivados de fenil-piperazina, fenil-piperidina y fenil-tetrahidropiridina como inhibidores de la reabsorcion de la serotonina, una composicion farmaceutica y utilizacion de los mismos para la preparacion de medicamentos | |
CO5590895A2 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos | |
AR035892A1 (es) | Derivados de oxazol, proceso para su preparacion, composiciones farmaceuticas que los comprenden, y el uso de dichos compuestos en la preparacion de medicamentos | |
HRP20080429T3 (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
CO5670358A2 (es) | Derivados de 2-piridona como inhibidores de la elastasa neutrofila y su uso | |
AR055878A1 (es) | Derivados de ciclopropanocarboxamida | |
PE20061335A1 (es) | Compuestos derivados de benzodioxano y benzodioxolano como moduladores del receptor 5-ht2c | |
PE20061144A1 (es) | DERIVADOS DE PIRROLIDINA Y PIPERIDINA ACETILENO COMO ANTAGONISTAS DE LOS RECEPTORES DE GLUTAMATO METABOTROPICO (mGluRs) | |
AR058124A1 (es) | Derivados de ftalazinona como inhibidores de parp-1 | |
UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
AR006906A1 (es) | Derivados de indazol sustituidos, composiciones farmaceuticas que los contienen, uso de los mismos e intermediarios de sintesis | |
AR031526A1 (es) | Nuevas fenilpiperazinas, composiciones farmaceuticas que las contienen, metodos para preparar los compuestos y las composiciones y uso de los compuestos en la preparacion de un medicamento. | |
UY32801A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
AR034174A1 (es) | Compuestos de benzoxazinona, procedimiento para su preparacion, composiciones farmaceuticas que lo comprenden, procedimiento para la preparacion de tales composiciones, y el uso de dichos compuestos o composiciones en la fabricacion de medicamentos | |
AR069607A1 (es) | Inhibidores de la estearoil-coa desaturasa | |
UY29739A1 (es) | Derivados de amidas o sales farmacéuticamente aceptables de los mismos, procesos de preparaciones farmacéuticas conteniéndolos y aplicaciones | |
CO6220956A2 (es) | Derivados de pirazolona como inhibidores de pde4 | |
CO5690581A2 (es) | Derivados de cicloalquilo 1,3-sustituidos que tienen grupos acidicos principalmente grupos heterociclicos; procedimientos para su preparacion y su uso como medicamentos | |
AR052332A1 (es) | Derivados de benzdioxanpiperazina con una afinidad combinada para receptores de dopamina-d2 y sitios de reabsorcion de serotonina, composiciones farmaceuticas que los contienen y su empleo como medicamentos para el tratamiento de enfermedades del snc | |
AR037211A1 (es) | Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1 | |
AR018619A1 (es) | Derivados de 8-fenilxantina utiles como inhibidores de fosfoestearasa gmp ciclica (pdes), preparacion, composiciones farmaceuticas formuladas con dichosderivados y uso de dichos derivados para la fabricacion de medicamentos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |